VTL — VGI Health Technology Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- AU$3.60m
- AU$3.83m
- AU$0.00m
Annual income statement for VGI Health Technology, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
R2015 June 30th | 2016 June 30th | 2017 June 30th | 2018 June 30th | 2019 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.78 | 0.103 | 0.084 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | -0.507 | -0.921 | -0.13 | 0 | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 21.9 | 21.7 | 6.25 | 0 | -2.75 |
| Operating Profit | -20.2 | -21.6 | -6.17 | 0 | 2.75 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.2 | -20.8 | -5.56 | 0 | 2.75 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19 | -20.8 | -5.57 | 0 | 2.75 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -20 | -21.5 | -5.57 | 0 | 2.75 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -20 | -21.5 | -5.57 | 0 | 2.75 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.031 | -0.018 | -1.19 | 0 | -0.003 |